Ionetix Revenue

Pharmaceutical Manufacturing • Delhi, Michigan, United States • 51-100 Employees

Ionetix revenue & valuation

Annual revenue	$27,000,000
Revenue per employee	$436,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$86,400,000
Total funding	$37,300,000

Key Contacts at Ionetix

Alexander Yordanov

Director, Cmc Product Development

Shannon Phillips

Director Of Quality Assurance And Quality Control

Nick Freiburger

Sr. Director - Alpha Operations

Wei Wendy

Senior Director Of Accounting And Finance

Brice Furr

Sr. Director Of Engineering

Michael Barr

Sr. Director, Construction Management

Andy Steele

Quality Assurance Program Director

Patrick Wright

Director Of Radiation Safety And Ehs - Alpha

Mark Freeman

Sr. Director Manufacturing And Supply Chain

Mark Freeman

Director Of Engineering

Company overview

Headquarters	3130 Sovereign Dr., Suite 5D, Lansing, MI 48911, US
Phone number	+15172524069
Website	ionetix.com
NAICS	3254
SIC	384
Keywords	Manufacturing, Pharmaceuticals, Diagnostics, Therapeutics, Radiopharmaceuticals, Cardiac Pet, Cyclotrons, Radioisotope Production, Targeted Alpha Therapy, N-13 Ammonia
Founded	2010
Employees	51-100
Socials

Ionetix Email Formats

Ionetix uses 3 email formats. The most common is {first initial}{last name} (e.g., jdoe@ionetix.com), used 67.3% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@ionetix.com	67.3%
{first name}{last name}	johndoe@ionetix.com	30.9%
{last name}{first initial}	doej@ionetix.com	1.8%

About Ionetix

Ionetix is a cyclotron and technology company providing full-service radioisotope production and end-to-end radiopharmaceutical manufacturing solutions by actively establishing a network of ION-12SCs installed on or near the campus of PET programs across the country. By covering all costs related to the installation and ongoing operation of the cyclotron and making N-13 Ammonia available to providers through a pay-by-the-dose model, we are making this critical tracer accessible and affordable to providers nationwide. Our more recent endeavors involve leveraging our growing network of radiopharmaceutical manufacturing locations to support the development and commercialization of targeted alpha therapy (TAT), an emerging cancer therapy utilizing alpha radionuclides. The time is now to harness the power to deliver cutting edge diagnostics and therapeutics. We encourage you to visit our website for more information or message our LinkedIn page with any questions.

Employees by Management Level

Total employees: 51-100

Seniority

Employees

Entry

Manager

Senior

Employees by Department

Ionetix has 43 employees across 8 departments.

Departments

Number of employees

Funding Data

Explore Ionetix's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2019-01-14	1	$37,300,000
2024-09-07	1	N/A

Funding Insights

$37,300,000

Total funding amount

Number of funding rounds

Ionetix Tech Stack

Discover the technologies and tools that power Ionetix's digital infrastructure, from frameworks to analytics platforms.

Ninja Forms

Form builders

Marionette.js

JavaScript frameworks

Underscore.js

JavaScript libraries

Vimeo

Video players

Swiper

JavaScript libraries

jQuery Migrate

JavaScript libraries

Apache HTTP Server

Web servers

jQuery

JavaScript libraries

PHP

Programming languages

WordPress

Blogs

Google Analytics

Analytics

Bootstrap

UI frameworks

Frequently asked questions

Ionetix is located in Delhi, Michigan, US.

You can reach Ionetix at +15172524069.

Ionetix generates an estimated annual revenue of $27,000,000. This revenue figure reflects the company's market position and business performance in its industry.

Ionetix has an estimated valuation of $86,400,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Ionetix was founded in 2010, making it 16 years old. The company has established itself as a significant player in its industry over this time.

Ionetix has approximately 51-100 employees. The company continues to grow its workforce to support its business operations and expansion.

Ionetix has raised a total of $37,300,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Ionetix

Alexander Yordanov

Director, Cmc Product Development

Shannon Phillips

Director Of Quality Assurance And Quality Control

Nick Freiburger

Sr. Director - Alpha Operations

Wei Wendy

Senior Director Of Accounting And Finance

Brice Furr